Here is a summary of the clinical note:

**Cancer Type and Stage:** The patient has non-resectable cholangiocarcinoma, with evidence of tumor burden and progression.

**Chief Complaint:** Abdominal pain, jaundice, and elevated liver enzymes.

**Medical History:** The patient has a history of hypertension, atrial fibrillation, mitral valve prolapse, osteoarthritis of the right hip, and cholangiocarcinoma. She has undergone previous treatments, including metal stent placement, radiation therapy, and chemotherapy.

**Diagnostic Tests:**

* Blood tests: Complete blood count, electrolyte panel, liver function tests, and coagulation studies.
* Imaging studies: Renal ultrasound, ERCP (endoscopic retrograde cholangiopancreatography), and cholangiogram.
* Procedures: ERCP with stent placement, PTBD (percutaneous transhepatic biliary drainage) placement, and balloon dilation of the left hepatic duct stent.

**Medications:**

* On admission: Cyanocobalamin, digoxin, folic acid, docusate sodium, senna, warfarin, metoprolol succinate XL, and oxycodone.
* At discharge: Digoxin, docusate sodium, oxycodone, ondansetron, polyethylene glycol, bisacodyl, morphine sulfate, pantoprazole, simethicone, and ranitidine.

**Treatment and Progression:**

* The patient underwent multiple ERCP procedures and interventional radiology treatments, but her liver enzymes and symptoms did not improve.
* After discussion with her providers and family, the patient decided to focus on comfort measures and was discharged with hospice care.
* The patient's warfarin was discontinued, and she was started on a pain medication and bowel regimen for her comfort.

**Discharge Disposition:** The patient was discharged home with hospice care and will continue to receive pain management and other supportive care as needed.